NASDAQ · Biotechnology

BCTX (BCTX) Stock

$3.53 +1.73% NASDAQ: BCTX Healthcare

Valuation

MetricValue
Price$3.53
Market Cap$6.65M
P/E Ratio-0.04
P/B Ratio0.29
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$31.60
52-Week Low$2.60
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-144.00%
ROA-120.00%
ROCE-158.33%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio5.40

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-9.0M$-20.0M$-31.0M$-46.0M$-38.0M
Net Profit$-17.0M$-34.0M$-27.0M$-7.0M$-36.0M
EPS$-585.01$-330.38$-261.86$-59.69$-86.25
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$73.0M$55.0M$36.0M$8.0M$30.0M
Total Liabilities$38.0M$41.0M$41.0M$12.0M$6.0M
Cash$72.0M$53.0M$28.0M$1.0M$14.0M
Borrowings$0$0$0$0$0

Latest News

BriaCell Opens First Canadian Site For Phase 3 Metastatic Breast Cancer Study MT Newswires · Jul 16, 2026 BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer GlobeNewswire · Jul 16, 2026 BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™ GlobeNewswire · Jul 15, 2026 BriaCell Engages Consulting and Branding Firms to Support Potential Commercialization of Bria-IMT MT Newswires · Jul 7, 2026 BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™ GlobeNewswire · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-10.0M$-16.0M$-32.0M$-33.0M$-39.0M
Investing Cash Flow$0$0$0$-2.0M$-11.0M
Financing Cash Flow$0$-13.0M$0$0$0
Net Cash Flow$72.0M$-21.0M$-26.0M$-28.0M$13.0M
Free Cash Flow$-10.0M$-16.0M$-32.0M$-34.0M$-39.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-466.42%
Quick Ratio10.19
Interest Coverage—
Return 1Y-48.83%
Return 3Y-93.89%
Return 5Y-91.72%

Ownership

Insiders Held0.51%
Institutions Held5.25%
Institutions Float Held5.27%
Institutional HolderSharesReport Date
Cable Car Capital, LP216,8212026-03-31
Sabby Management, LLC73,9152026-03-31
Iridian Asset Management LLC65,0002026-03-31
Luminarx Capital Management LP15,0002026-03-31
UBS Group AG11,5412026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About BCTX

BCTX is led by CEO William V. Williams, employs 16 people, headquartered in CA, publicly traded since 2012.

BCTX stock trades at $3.53 with a market capitalization of $6.65M. The stock is valued at a price-to-earnings (P/E) ratio of -0.04, price-to-book of 0.29, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.60 and $31.60, and currently trades 88.8% below its 52-week high.

On profitability, BCTX generates a return on equity (ROE) of -144.00%, return on capital employed of -158.33%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides